A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918
- Status
- TERMINATED
- Phase
- PHASE1
Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2